Teva Pharmaceuticals at heart of major price fixing suit in US - www.israelhayom.com
Teva boss hits out at opioid lawsuits | Financial Times
Teva Pharm to lay off a quarter of workforce, suspends dividend
Teva to Pay $420M to Settle Shareholders' Generic Drug Pricing Lawsuit — Report
Israel's Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits
/cloudfront-us-east-2.images.arcpublishing.com/reuters/QC7ATUSFPVOG5IF4BPJYEZ7FWE.jpg "TEVA.TA - Teva Pharmaceutical Industries Limited | Stock Price & Latest News | Reuters")
TEVA.TA - Teva Pharmaceutical Industries Limited | Stock Price & Latest News | Reuters
Teva may pay as much as $3.6 billion in opioid settlement | Business Insurance
Teva Pharmaceutical Industries Ltd
Teva Pharmaceuticals to Lay Off 14,000 People
Florida reaches $878 million opioid settlements with CVS, Teva, others By Reuters
Teva CEO Exits Amid Crisis of Confidence at Drugmaker
/s3.amazonaws.com/arc-authors/reuters/95edf7b8-0bf7-4687-a004-a26423a1aae0.png "Teva Pharmaceutical Industries Ltd.")
Teva Pharmaceutical Industries Ltd.
Teva could pay $3.6b to settle opioid dispute - report - Globes
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
/cloudfront-us-east-2.images.arcpublishing.com/reuters/AP6KIV5ZJZMMXHJ3TT4TTMV3MQ.jpg "Teva, Texas strike opioid settlement worth $225 million | Reuters")
Teva, Texas strike opioid settlement worth $225 million | Reuters
Teva reaches proposed settlement of opioid lawsuits | Business Insurance
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel
Drugmaker Teva looks to sell Medis business to help cut debt | Reuters
Walgreens, Teva accused of fueling opioid addiction in quest for new markets | Reuters
San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters
Teva Partners with Tikun Olam-Cannbit to Sell Medical Cannabis Products – Report
San Francisco reaches $58 mln opioid settlement with Teva, Allergan | Reuters
TEVA stock lower as company eyes up to $3.6 billion to settle opioid claims - Reuters | Seeking Alpha
Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625
Teva's $15B free drug opioid settlement might be a great deal in the long run: analyst | Fierce Pharma
CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports | Ctech
Teva Names Interim CEO, New Chairman As Vigodman Steps Down
Teva lied about opioid role, New York says | Reuters
A Teva Pharmaceutical Industries building is seen in Jerusalem December 14, 2017. REUTERS/Ammar Awad Stock Photo - Alamy
